RevitaPROST capsules for prostatitis are easy to take and with their help you can quickly achieve the desired result and get rid of the disease. The leading urologists in our country recommend them to all their patients with prostate inflammation problem to quickly restore men's health and prevent relapses.
Clinical studies and experience of widespread use of the drug prove that the drug has no contraindications. It is based only on natural ingredients that do not harm the body, without fragrances, dyes or chemical compounds. The product can be taken together with other medications, therefore it does not cause adverse reactions and does not interact with chemical elements.
The composition characteristics of RevitaPROST allow you to obtain the best result, as each of its components enhances the effect of the other. This gives us the right to assert that these capsules for the treatment of prostatitis are unique and have no analogues in the world.
Urological experts advise all men with prostatitis problems to take the medicine as directed, as well as for its prevention. The disease is usually accompanied by the following symptoms:
Treatment should begin immediately as soon as signs of the disease are detected. This will help avoid serious complications such as tumors, infertility, vesiculitis, impotence, pelvic pain and urinary incontinence.
RevitaPROST has no serious contraindications for use. An exception may be individual intolerance to the ingredients included in this product. There are no age restrictions, but you must strictly follow the manufacturer's recommendations.
To get results, you need to know how to use RevitaPROST capsules, produced in Austria, to eliminate prostate inflammation. Each package of the medicine contains detailed instructions with a description. The daily dose is two capsules, which are taken orally, one at a time, 10 to 12 hours apart. It is most convenient to take the first dose half an hour before breakfast and the second dose 10 minutes before dinner. Drink with clean, still water. The duration of therapy depends on the severity of the disease, usually the average course is calculated for two months.
